SuperworthVerastem market cap VSTM
Share price times shares outstanding: what the whole company sells for, since 2012.
- Today, Oct 23, 2026
- $909.3M
- Highest close in our data
- $909.3M
- Oct 2026
Verastem is worth $909.3M at the close on Oct 23, 2026, at $10.04 a share.
That is up 86% over the last year and up 93% over five years.
Its highest close in our data was $909.3M in Oct 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $909.3M | $326M | $909.3M | +69% |
| 2025 | $538.2M | $228M | $710.5M | +226% |
| 2024 | $165.1M | $63.6M | $334M | −20% |
| 2023 | $205.7M | $74.3M | $261.6M | +145% |
| 2022 | $84M | $58.2M | $344.3M | −77% |
| 2021 | $373.5M | $331.1M | $820.1M | +3% |
| 2020 | $361.6M | $96.7M | $612.9M | +247% |
| 2019 | $104.1M | $66.9M | $278M | −60% |
| 2018 | $258.8M | $120.3M | $733M | +108% |
| 2017 | $124.3M | $41.8M | $200.1M | +200% |
| 2016 | $41.4M | $41M | $61M | −40% |
| 2015 | $68.7M | $64.6M | $435.1M | −69% |
| 2014 | $221.4M | $192.5M | $385.2M | −26% |
| 2013 | $300.3M | $192.7M | $366M | +78% |
| 2012 | $169M | $143.3M | $234.2M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Verastem's size, closest first, today.
| Company | Market cap |
|---|---|
| VSTMVerastem | $909.3M |
| ABUSArbutus Biopharma | $831M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| COLLCollegium Pharmaceutical | $747.5M |
| OMEROmeros | $1.2B |
| CRMDCorMedix | $611.9M |
| ZVRAZevra Therapeutics | $582.6M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| PCRXPacira BioSciences | $1.5B |
| PBYIPuma Biotechnology | $568.9M |
| ANABAnaptysbio | $1.5B |
| Peer median | $789.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Verastem
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.